CD8A and neoplasm: More importantly, these studies support the concept that both MHC-I– and MHC-II–restricted neoantigens need to be processed and presented by APCs, indicating that APCs shape anti-tumor immunity by coordinating the collaboration of CD4 and CD8 T cells.